Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
11,549,491
-
Total 13F shares
-
2,068,834
-
Share change
-
+163,891
-
Total reported value
-
$13,736,198
-
Put/Call ratio
-
206%
-
Price per share
-
$6.64
-
Number of holders
-
26
-
Value change
-
+$169,055
-
Number of buys
-
12
-
Number of sells
-
22
Institutional Holders of TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) as of Q3 2022
As of 30 Sep 2022 TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) had 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,068,834 shares of stock of the company.
Largest 10 holders included Rubric Capital Management LP, VANGUARD GROUP INC, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, J. Goldman & Co LP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, SANDERS MORRIS HARRIS LLC, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, GROUP ONE TRADING, L.P., and GABELLI FUNDS LLC.
This table shows 26 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.